RxDoctor Payments Data

Tyler Darland, MD

Family Medicine · Atchison, KSNPI 1588190276

Payments from drug & device makers

$1,359in general payments, 2019–2025

Across 84 payments — averaging $16.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$220
  • Amgen$192
  • Lilly USA, LLC$158
  • AstraZeneca$88
  • Amarin Pharma, Inc.$68
  • Pfizer$58
  • plus $575 from 21 others

What the payments were for

  • Food & beverage$1,359100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,359 in reported general payments places this provider in the 65th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$3,939
Medicare patients
24
Services billed
44

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban247$86,992
JardianceEmpagliflozin104$53,152
OzempicSemaglutide46$46,061
TrulicityDulaglutide27$29,897
RybelsusSemaglutide21$24,122
Efavirenz-Emtric-Tenofov DisopEfavirenz/Emtricit/Tenofovr Df12$21,613
VraylarCariprazine Hcl11$18,433
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl42$14,527
FarxigaDapagliflozin Propanediol20$13,356
NuedextaDextromethorphan Hbr/Quinidine15$11,767
JanuviaSitagliptin Phosphate26$11,055
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$11,028
Tresiba Flextouch U-100Insulin Degludec20$10,408
TrulancePlecanatide13$8,449
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$7,720

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$58$86,992247 claims
Novo NordiskOzempic, Rybelsus$48$70,18467 claims
Boehringer IngelheimJardiance$25$53,152104 claims
Lilly USA, LLCTrulicity$158$29,89727 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$88$26,91148 claims
AbbVieVraylar$220$18,43311 claims
GSKTrelegy Ellipta, Arnuity Ellipta, Incruse Ellipta$55$16,24543 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$36$8,44913 claims
Astellas Pharma US IncMyrbetriq$16$3,47815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Atchison

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →